PET/CT showed high uptake of 18 F-FDG in most tumor lesions, and the SUV max of the different treatment groups showed extremely significant differences compared with the blank control group ( figure 3f, 3g, 3h ).
← all excerpts
Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.
1
—
—